KAISER PETER (Chief Development Officer) sold 1.5% of their position (3.01K shares) of OCULAR THERAPEUTIX, INC on the open market
Open‑market sale worth $36.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/27/2025ACC: 0001104659-25-084117
Officer· Chief Development Officer
Since Feb 2026
-3.01K
Net shares
Net seller
$36.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.01K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.01K
Price / share
$12.04
Trade value
$36.25K
% of position
1.5%
8/25/2025
207.10K→204.09K
Total
Net shares
−3.01K
Net value
-$36.25K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/25/2025 | S · Sale | −3.01K | $12.04 | $36.25K | 1.5% | 207.10K | 204.09K |
| Total | −3.01K | -$36.25K | ||||||
Derivative Transactions0
No derivative transactions reported